Quick Answer
Zai Lab Ltd reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
Zai Lab Ltd Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.16 | +38.5% |
| 2024 | -$0.26 | +25.7% |
| 2023 | -$0.35 | +23.9% |
| 2022 | -$0.46 | +39.5% |
| 2021 | -$0.76 | -117.1% |
| 2020 | -$0.35 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.03 | +25.0% | +25.0% |
| June 30, 2025 | -$0.04 | +50.0% | +0.0% |
| March 31, 2025 | -$0.04 | +20.0% | +0.0% |
| September 30, 2024 | -$0.04 | +42.9% | +50.0% |
| June 30, 2024 | -$0.08 | +38.5% | -60.0% |
| March 31, 2024 | -$0.05 | +0.0% | +28.6% |
| September 30, 2023 | -$0.07 | +58.8% | +46.2% |
| June 30, 2023 | -$0.13 | +7.1% | -160.0% |
- Zai Lab Ltd showed an increase of +38.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Zai Lab Ltd’s diluted eps has grown by 54.3% (from $0.35 per share (loss) to $0.16 per share (loss)).
- The most recent figure is from Zai Lab Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: